Ana O. Hoff

7.8k citations

104 papers · 4.7k indexed · 2 hit papers · h-index 29

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Thyroid Cancer Diagnosis and Treatment
Orthopedics and Sports Medicine top 1%
- Bone and Joint Diseases

Papers in

Endocrinology, Diabetes and Metabolism 68
- Thyroid Cancer Diagnosis and Treatment 53
- Pituitary Gland Disorders and Treatments 13
Orthopedics and Sports Medicine 10

Co-authors: Robert F. Gagel Steven I. Sherman Bruce Robinson Marcia S. Brose Makoto Tahara Corina E. Dutcus Naomi Kiyota Gilbert J. Cote
Journals: Journal of Clinical Oncology (8 papers)Thyroid (7 papers)Annals of Oncology (5 papers)Cancer (4 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)
Partner nations: Brazil United States Australia

In The Last Decade

Ana O. Hoff

94 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial 2021 · 156 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 The Lancet Oncology
2015 New England Journal of Medicine

Peers

Countries citing papers authored by Ana O. Hoff

Since Specialization

Citations

This map shows the geographic impact of Ana O. Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana O. Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana O. Hoff more than expected).

Fields of papers citing papers by Ana O. Hoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana O. Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana O. Hoff. The network helps show where Ana O. Hoff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ana O. Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ana O. Hoff Line = papers co-authored together Ana O. Hoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	8659 Aldosterone-Secreting Adrenocortical Carcinoma: A Rare Cause Of Primary Hyperaldosteronism Associated With Dismal Outcome Journal of the Endocrine Society ·Masato Osawa, شريفة بلحوتس, Greg Michael McKean, Myrthe de Koning, Fernando Morgadinho Santos Coelho, Praveenkumar Cheruvu, Martin Hyben, Ana O. Hoff, Jose L Chambô, Victor Srougi, Koya Taira, Ana Cláudia Latronico, Madson Q. Almeida, Berenice B. Mendonça, Maria Candida Barisson Villares Fragoso	2024	0
2	Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma The Journal of Clinical Endocrinology & Metabolism ·Aurélie Adler, 吴晓云, Kavya P., Yangyang Yan, Giancarlo Pavia, Mariana F.A. Funari, Geir Ottersen, 美光酒井, Maria Adelaide A. Pereira, Martin Hyben, M. Ferrari, Zachary Ohs, Victor Srougi, Fábio Y Tanno, Jose L Chambô, Ana Cláudia Latronico, Berenice B. Mendonça, Maria Candida Barisson Villares Fragoso, Ana O. Hoff, Madson Q. Almeida	2023	4
3	Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective Reviews in Endocrine and Metabolic Disorders ·Fabián Pitoia, Rafael Selbach Scheffel, 啓子武立, Gao Tian-le, Hernán Tala, Fernanda Vaisman, Alejandro Román-Gonzaléz, Ana O. Hoff, Ana Luiza Maia	2023	6
4	Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study Thyroid ·Jaume Capdevila, Jolanta Krajewska, Jorge Hernando, Bruce Robinson, Steven I. Sherman, Barbara Jarząb, Chia‐Chi Lin, Fernanda Vaisman, Ana O. Hoff, Erika Hitre, Daniel W. Bowles, R. Sessiz Ak, Roman M. Levytskyy, Jennifer Oliver, Bhumsuk Keam, Marcia S. Brose	2023	6
5	Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM) Archives of Endocrinology and Metabolism ·Laura Sterian Ward, Rafael Selbach Scheffel, Ana O. Hoff, Carolina Ferraz, Fernanda Vaisman	2022	11
6	How to Identify Cervical Traumatic Neuromas in the Post-operative Neck Dissection: Brief Review of the Cervical Plexus Ultrasound Ultrasound in Medicine & Biology ·Jay Rome O. de los Santos, Marco Aurélio Vamondes Kulcsar, Ana O. Hoff, Maria Cristina Chammas, Ricardo Miguel Costa de Freitas	2022	0
7	Choosing Wisely for Thyroid Conditions: Recommendations of the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism Archives of Endocrinology and Metabolism ·José Miguel Dora, Rosa Paula M. Biscolla, M Salanca, Janete M. Cerutti, Hans Graf, Ana O. Hoff, Gláucia Maria Ferreira da Silva Mazeto, Patrícia Künzle Ribeiro Magalhães, Cléo Otaviano Mesa, Rafael Selbach Scheffel, Patrícia de Fátima dos Santos Teixeira, Fernanda Vaisman, B.L. Sucgang, Ana Luiza Maia	2021	3
8	Thyroid collision tumor containing oncocytic carcinoma, classical and hobnail variants of papillary carcinoma and areas of poorly differentiated carcinoma Archives of Endocrinology and Metabolism ·Marcos Tadashi Kakitani Toyoshima, Farnaz Taherkhani, Iberê Cauduro Soares, Debora Lúcia Seguro Danilovic, M. Blogie, Садагат Агасафар кызы Алиева, Xin Shi, Felipe Roitberg, Ana O. Hoff	2021	9
9	Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases Endocrine ·Ke Liu, Leandro Luongo Matos, Hanna Laine, Stephen Manning, Thomas Gillam, Marco Aurélio Vamondes Kulcsar, Ana O. Hoff, Luiz Paulo Kowalski, 文代宮田	2021	11
10	Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer European Journal of Cancer ·Makoto Tahara, Naomi Kiyota, Ana O. Hoff, Corin Badiu, Taofeek K. Owonikoko, Corina E. Dutcus, Takuya Suzuki, Min Ren, Lori J. Wirth	2021	37
11	Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Oncology ·Marcia S. Brose, Bruce Robinson, Steven I. Sherman, Jolanta Krajewska, Chia‐Chi Lin, Fernanda Vaisman, Ana O. Hoff, Erika Hitre, Daniel W. Bowles, Jorge Hernando, Leonardo Faoro, Kamalika Banerjee, Jennifer Oliver, Bhumsuk Keam, Jaume Capdevila Hit paper breakdown →	2021	156
12	Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas? Thyroid ·Debora Lúcia Seguro Danilovic, Luciana Audi Castroneves, Cláudia Kimie Suemoto, 瑠美野辺, Iberê Cauduro Soares, R. Y. A. Camargo, Fernanda A. Correa, Ana O. Hoff, Suemi Marui	2020	33
13	Crossed-Probes Cryoablation for the Treatment of a Sclerotic Vertebral Metastasis Abutting the Spinal Canal Journal of Vascular and Interventional Radiology ·Ricardo Miguel Costa de Freitas, José Guilherme Mendes Pereira Caldas, Р.В. Некрасов, Ana O. Hoff, João Evangelista Bezerra Neto, Maria Candida Barisson Villares Fragoso	2020	0
14	Comparison of 18F-NaF PET/CT with Other Imaging Methods in the Detection of Bone Metastases in Patients with Medullary Thyroid Cancer: a Report of a Series of 31 Cases Nuclear Medicine and Molecular Imaging ·Latifatul Imamah, Paulo Schiavom Duarte, Luciana Audi Castroneves, George Barbério Coura-Filho, Thecla Fitz-Lewis, Marcelo Tatit Sapienza, Ana O. Hoff, Carlos Alberto Buchpiguel	2020	9
15	Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer New England Journal of Medicine ·Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hoff, Andrew G. Gianoukakis, Naomi Kiyota, Matthew H. Taylor, Sung‐Bae Kim, Monika K. Krzyzanowska, Corina E. Dutcus, Begoña de las Heras, Junming Zhu, Steven I. Sherman Hit paper breakdown →	2015	1408
16	Complete Resolution of Hypercortisolism with Sorafenib in a Patient with Advanced Medullary Thyroid Carcinoma and Ectopic ACTH (Adrenocorticotropic Hormone) Syndrome Thyroid ·Romualdo Barroso‐Sousa, Antônio Marcondes Lerário, Joao Evangelista, Lukui Jin, Delmar Muniz Lourenço, H. Lee, Marco Aurélio Vamondes Kulcsar, Maria Candida Barisson Villares Fragoso, Ana O. Hoff	2014	26
17	Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer Head & Neck ·Libero Santarpia, Robert F. Gagel, Steven I. Sherman, Nicholas J. Sarlis, Douglas B. Evans, Ana O. Hoff	2008	19
18	Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer Journal of Oncology Practice ·Salvatore L. Ruggiero, Julie R. Gralow, Robert E. Marx, Ana O. Hoff, Mark M. Schubert, Joseph M. Huryn, B. Tóth, Kathryn Damato, Vicente Valero	2006	259
19	Ablation of calcitonin/calcitonin gene-related peptide-α impairs fetal magnesium but not calcium homeostasis American Journal of Physiology-Endocrinology and Metabolism ·Syamyan Gorgi Zahir, Neva J. Fudge, Rizwan Jeelani, James K. Friel, Ana O. Hoff, Robert F. Gagel, Christopher S. Kovács	2004	19
20	A Novel Point Mutation of theRETProtooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma The Journal of Clinical Endocrinology & Metabolism ·Camilo Jiménez, Singgih Permana, Pamela N. Schultz, Adel K. El‐Naggar, Suzanne E. Shapiro, Elizabeth Barnes, Douglas B. Evans, Rena Vassilopoulou‐Sellin, Robert F. Gagel, Gilbert J. Cote, Ana O. Hoff	2004	32

About Ana O. Hoff

Ana O. Hoff is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, Oncology, Cancer Research and Nephrology, having authored 104 papers that have together received 4.7k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (53 papers), Neuroendocrine Tumor Research Advances (18 papers), Adrenal and Paraganglionic Tumors (14 papers), Pituitary Gland Disorders and Treatments (13 papers), Bone health and treatments (13 papers), Cancer, Hypoxia, and Metabolism (11 papers), Thyroid and Parathyroid Surgery (8 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Orthopedics and Sports Medicine (763 citations), Oncology (1.9k citations), Cancer Research (337 citations) and Surgery (868 citations). Ana O. Hoff has collaborated with scholars based in Brazil, United States and Australia. Frequent co-authors include Robert F. Gagel, Steven I. Sherman, Bruce Robinson, Marcia S. Brose, Makoto Tahara, Corina E. Dutcus, Naomi Kiyota, Gilbert J. Cote, Lori J. Wirth and Matthew H. Taylor. Their work appears in journals such as Journal of Clinical Oncology, Thyroid, Annals of Oncology, Cancer and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact